Last reviewed · How we verify
NCT06854146
The Effect of Environmental Factors on Gastric Cancer Based on Macrogenome
trial testing gastric cancer in Gastric Cancers in 200 participants. Participants enrolled and being followed up; not accepting new ones.
1 November 2027
Quick facts
| Lead sponsor | Dong Peng |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 1 November 2024 |
| Primary completion | 1 November 2027 |
| Estimated completion | 1 November 2027 |
| Sites | 1 location across China |
Drugs / interventions tested
- gastric cancer
- healthy
Conditions studied
- Gastric Cancers — all drugs for Gastric Cancers →
- Air Pollution — all drugs for Air Pollution →
Sponsor
Dong Peng
Who can join
18 and older, any sex, with Gastric Cancers or Air Pollution. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objectives of this study were to clarify how environmental factors such as air pollution affect the occurrence and development of gastric cancer; to identify patient-specific macrogenomic markers of gastric cancer; and to investigate the mechanism of gastric cancer development based on environmental factors and macrogenomic data.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06854146
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of gastric cancer
Trials testing the same drug.
- NCT06856382 — The Association Between Microplastics and Macrogenomics and Metabolomics in Gastric Cancer · active not recruiting
- NCT06686966 — Prediction of Postoperative Complications and Survival in Gastric Cancer Using Preoperative Blood Markers · completed
Other recruiting trials for Gastric Cancers
Currently open trials in the same condition.
- NCT06766305 — QL1706 Combined With SOX Used in Theperioperative Treatment · Phase 1, PHASE2 · recruiting
- NCT07003334 — Correlation of Psychological Distress and Immune Checkpoint Inhibitors in Gastric Cancer · recruiting
- NCT06856382 — The Association Between Microplastics and Macrogenomics and Metabolomics in Gastric Cancer · active not recruiting
- NCT06895447 — Robotic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant Therapy · Phase 2 · recruiting
- NCT06632886 — AI-Assisted Non-Contrast CT for Multi-Cancer Screening · NA · recruiting
Other Dong Peng trials
Trials by the same sponsor.
- NCT07126743 — Organic Pollutant Build-Up in Body Fat and Stomach Tissue Linked to Obesity Levels · active not recruiting
- NCT07063550 — Microplastics in Paraneoplastic and Intratumoral for Colorectal Cancer · active not recruiting
- NCT06856382 — The Association Between Microplastics and Macrogenomics and Metabolomics in Gastric Cancer · active not recruiting
- NCT06852495 — the Effect of Environmental Factors on Colorectal Cancer Based on Macrogenomes · active not recruiting
- NCT06641700 — Predictive Value of Air Pollution and Metabolomics for Gastric Cancer. · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06854146 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dong Peng
- Last refreshed: 3 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06854146.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing